Partnership expands global footprint and capabilities in functional diagnostic testing
SEATTLE, Wash. – March 10, 2026 – Pike Street Capital portfolio company, US BioTek Laboratories (“US BioTek”) announces that it has completed a strategic investment in NutriPATH (“NutriPATH”), a provider of functional pathology services based in Melbourne, Australia. The partnership expands the product portfolio and geographic footprint of the combined organization, enabling it to deliver a broader range of diagnostic laboratory tests to healthcare providers across key international markets.
Like US BioTek, NutriPATH is a CLIA-accredited clinical laboratory, and is additionally accredited under the internationally recognized ISO 15189 standard. Recognized for its expertise in functional pathology, nutritional assessment, and gut health diagnostics, NutriPATH has been an OEM partner to US BioTek for several years, making this a natural extension of a long-standing collaboration.
“This acquisition marks an exciting new chapter for both US BioTek and NutriPATH”, said Jack Frausing, CEO of US BioTek Laboratories. “Our shared philosophy centers on providing clinicians with meaningful data they can trust and apply in practice. By bringing our teams and capabilities together, we are strengthening our ability to support practitioners with deeper insights, improved access, and expanded innovation.”
NutriPATH will continue operating under its established brand in Australia, ensuring continuity for practitioners while benefiting from access to additional resources, technologies, and shared scientific expertise.
”This combination brings together complementary testing capabilities while expanding the platform’s international reach,” said Dave Dandel, Partner at Pike Street Capital. “We see significant opportunity to build on the combined strengths of both organizations to support a broader global customer base and address growing demand within the functional medicine and wellness markets.”
About US BioTek Laboratories
US BioTek Laboratories is a leading functional laboratory dedicated to delivering advanced immunological and specialty testing to integrative, functional, and personalized healthcare providers. Known for its expertise in food sensitivity testing, immune markers, toxin testing, and clinically actionable reporting, US BioTek partners closely with practitioners to support data-driven, patient-centered care. More information is available at www.usbiotek.com.
About About NutriPATH
NutriPATH is a functional pathology laboratory based in Melbourne, Australia, providing comprehensive testing solutions across gut health, nutritional status, hormones, and metabolic markers. NutriPATH is widely recognized for its practitioner education, clinical support, and commitment to advancing functional medicine diagnostics. More information is available at nutripath.com.au